143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f
Alzheimer's disease is composed of four distinct subtypes

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no

Alzheimer's disease is composed of four distinct subtypes

by Lund UniversityCredit: Unsplash/CC0 Public DomainAlzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can no
No cure for Alzheimer's disease in my lifetime

No cure for Alzheimer's disease in my lifetime

by Norman A. Paradis,The ConversationCredit: SAM LIN from PexelsBiogen recently announced that it was abandoning its late stage drug for Alzheimer's,aducanumab, causing investors to&nb

No cure for Alzheimer's disease in my lifetime

by Norman A. Paradis,The ConversationCredit: SAM LIN from PexelsBiogen recently announced that it was abandoning its late stage drug for Alzheimer's,aducanumab, causing investors to&nb
Alzheimer's: Nicotinic receptors as a new therapeutic target

Alzheimer's: Nicotinic receptors as a new therapeutic target

by Institut PasteurRepresentation of space in the nicotinic receptor. Credit: Institut PasteurSeveral scientific studies have indicated that nicotine may be beneficial for memory function. Scientists

Alzheimer's: Nicotinic receptors as a new therapeutic target

by Institut PasteurRepresentation of space in the nicotinic receptor. Credit: Institut PasteurSeveral scientific studies have indicated that nicotine may be beneficial for memory function. Scientists
Alzheimer's drug trial shows 'evidence of sustained improvement'

Alzheimer's drug trial shows 'evidence of sustained improvement'

by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi

Alzheimer's drug trial shows 'evidence of sustained improvement'

by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi
Advances along the gut-liver-brain axis in Alzheimer's disease

Advances along the gut-liver-brain axis in Alzheimer's disease

by Alzheimer's AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainFour new studies reported at the Alzheimer's Association International Conference (AAIC)

Advances along the gut-liver-brain axis in Alzheimer's disease

by Alzheimer's AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainFour new studies reported at the Alzheimer's Association International Conference (AAIC)
Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval
Alzheimer research: Noise-inducing neurons shut down memories

Alzheimer research: Noise-inducing neurons shut down memories

by German Center for Neurodegenerative DiseasesCredit: Public DomainNeurons that are responsible for new experiences interfere with the signals of neurons that contain memories and thereby distur

Alzheimer research: Noise-inducing neurons shut down memories

by German Center for Neurodegenerative DiseasesCredit: Public DomainNeurons that are responsible for new experiences interfere with the signals of neurons that contain memories and thereby distur
Immune system dysfunction may occur early in Alzheimer's disease

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu
Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease
New discovery for how the brain 'tangles' in Alzheimer's disease

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that